Regeneron Pharmaceuticals

REGN · United States · Biotechnology · matched S&P 500 member. Follow its market-weight contribution.

Historical time machine

Historical observation

20182026

Universe weight

0.244%

12M weight contribution

+0.052 pp

3M weight contribution

-0.006 pp

12M price return

+24.6%

Share of matched S&P 500 members

Monthly observations through Jan 2023

Company price index

A separate dimension from market allocation

Historical observations

Most recent 24 observations at or before the selected month

Month	Market cap	Universe weight	12M weight change	12M return	Above 6M weight average
Jan 2023	$71.3bn	0.244%	+0.052 pp	+24.6%	Yes
Dec 2022	$67.8bn	0.245%	+0.055 pp	+14.2%	Yes
Nov 2022	$70.6bn	0.240%	+0.038 pp	+18.1%	Yes
Oct 2022	$70.3bn	0.250%	+0.049 pp	+17.0%	Yes
Sep 2022	$64.7bn	0.254%	+0.055 pp	+13.8%	Yes
Aug 2022	$54.6bn	0.195%	-0.016 pp	-13.7%	No
Jul 2022	$54.7bn	0.188%	+0.003 pp	+1.2%	No
Jun 2022	$55.5bn	0.216%	+0.031 pp	+5.8%	Yes
May 2022	$62.5bn	0.225%	+0.056 pp	+32.3%	Yes
Apr 2022	$61.9bn	0.224%	+0.060 pp	+36.9%	Yes
Mar 2022	$65.6bn	0.221%	+0.134 pp	+47.6%	Yes
Feb 2022	$58.1bn	0.202%	+0.117 pp	+37.2%	Yes
Jan 2022	$57.2bn	0.192%	+0.079 pp	+20.8%	No
Dec 2021	$59.3bn	0.190%	+0.006 pp	+30.7%	No
Nov 2021	$59.8bn	0.202%	-0.004 pp	+23.4%	Yes
Oct 2021	$60.1bn	0.201%	-0.041 pp	+17.7%	Yes
Sep 2021	$56.9bn	0.200%	+0.199 pp	+8.1%	Yes
Aug 2021	$63.3bn	0.212%	+0.211 pp	+8.6%	Yes
Jul 2021	$54.0bn	0.185%	+0.185 pp	-9.1%	Yes
Jun 2021	$52.5bn	0.185%	+0.185 pp	-10.4%	Yes
May 2021	$47.2bn	0.169%	+0.169 pp	-18.0%	Yes
Apr 2021	$45.2bn	0.164%	-0.113 pp	-8.5%	Yes
Mar 2021	$44.5bn	0.087%	+0.087 pp	-3.1%	No
Feb 2021	$42.3bn	0.085%	+0.084 pp	+1.3%	No

Its weight is estimated market cap divided by the total estimated market cap of matched S&P 500 members for the month. This is not an official float-adjusted S&P index weight.